Sprain Clinical Trial
Ortheses are commonly used for the repair of damage to the musculoskeletal system. However, immobility, by itself, causes serious side effects that require long and costly rehabilitation. The Sensory Feedback Ortheses allow to artificially maintain the proprioceptive and tactile flow in order to maintain the activity of their host brain areas and thus reduce significantly the usual therapy duration. The clinical study Orthosens will evaluate the efficacy and safety of the Sensory Feedback Ortheses.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00765700 -
Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury
|
Phase 3 | |
Recruiting |
NCT02285868 -
ATI Evidence-based Guide Investigating Clinical Services
|
||
Withdrawn |
NCT00954785 -
Etoricoxib in Acute Ankle Ligament Sprains
|
Phase 4 | |
Completed |
NCT02916940 -
Injection of Corticoids for the Treatment of Acute Sprains of the Proximal Interphalangeal Joints of the Fingers.
|
Phase 2 | |
Completed |
NCT00351104 -
Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Ankle Sprain or Strain
|
Phase 3 | |
Completed |
NCT00671320 -
A Multi-Center, Randomized, Double-Blind, Parallel Group Study To Compare The Efficacy And Tolerability Of Valdecoxib And Diclofenac In Patients With A Sprained Ankle
|
Phase 4 | |
Not yet recruiting |
NCT02346786 -
Epidemiology of Incidents and Accidents in Sport. Influence of Moisture.
|
Phase 3 | |
Completed |
NCT00601471 -
Effects of Proximal and Distal Tibiofibular Joint Manipulation on Lower Extremity Muscle Activation, Ankle Range of Motion, and Functional Outcome Scores in Individuals With Chronic Ankle Instability
|
N/A | |
Withdrawn |
NCT01223053 -
Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury
|
Phase 3 |